Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:1654
currentissue backissue special isse search   Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2015  |  Volume : 8  |  Issue : 1  |  Page : 16
T cell epitopes within envelope glycoprotein of Ebola virus: The clue for vaccine development


1 Visiting Professor, Hainan Medical University, Haikou, China,
2 Wiwanitkit House, Bangkhae, Bangkok, Thailand

Click here for correspondence address and email

Date of Web Publication8-May-2015
 

How to cite this article:
Wiwanitkit V, Wiwanitkit S. T cell epitopes within envelope glycoprotein of Ebola virus: The clue for vaccine development. Ann Trop Med Public Health 2015;8:16

How to cite this URL:
Wiwanitkit V, Wiwanitkit S. T cell epitopes within envelope glycoprotein of Ebola virus: The clue for vaccine development. Ann Trop Med Public Health [serial online] 2015 [cited 2019 Jun 16];8:16. Available from: http://www.atmph.org/text.asp?2015/8/1/16/156709
Dear Sir,

The 2014 Ebola virus epidemic in western Africa is the present concern in global public health. [1],[2] This outbreak is believed to be one of the serious infectious epidemics in history. Generally, Ebola virus infection is a severe viral infection with high mortality. The disease is difficult to control due to lack of vaccination. To create a new vaccine, knowledge on the epitope within the virus molecule is required. Here, the author reports the preliminary assessment to find T cell epitopes within envelope glycoprotein of Ebola virus. The author used the standard immunomincs technique for analysis on the available standard Ebola virus envelope glycoprotein [Accession: Q05320.1, guard interval (GI): 465411] derived from the PubMed database. The details of the immunomics method used in this study are the same as the protocol used in the previously published work by Wiwanitkit. [3] According to the analysis, the nonapeptides starting at position 439, 251, and 502 are the parts that have the highest scores of T cell epileptopigenicity. Interestingly, the derived nonapeptide "STDFLDPAT" is not the same, as previously reported by Wu et al. ("LYDRLASTV"). [4] The data from this study could be the clue for further development of vaccines.

 
   References Top

1.
Reynard O, Volchkov V, Peyrefitte C. A first outbreak of Ebola virus in West Africa. Med Sci (Paris) 2014;30:671-3.  Back to cited text no. 1
    
2.
Gulland A. Health ministers in West Africa hold crisis talks on Ebola virus. BMJ 2014;348:g4478.  Back to cited text no. 2
    
3.
Wiwanitkit V. Finding a T-cell epitope for a melanoma vaccine by an immunomics technique. Asian Pac J Cancer Prev 2006;7:659-60.  Back to cited text no. 3
    
4.
Wu S, Yu T, Song X, Yi S, Hou L, Chen W. Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins. Virol J 2012;9:111.  Back to cited text no. 4
    

Top
Correspondence Address:
Prof. Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160 Thailand

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.156709

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


    References

 Article Access Statistics
    Viewed692    
    Printed22    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    

Recommend this journal